Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A T Hirsch

Showing results (11-20 of 60) with videos related to

Pageof 6
Sort By:
Circulation|May 1, 1987
Baroreceptor function in congestive heart failure: effect on neurohumoral activation and regional vascular resistanceA T Hirsch, V J Dzau, M A Creager
Catheterization and Cardiovascular Diagnosis|January 1, 1988
Detection and treatment of high-output cardiac failure resulting from a large hemodialysis fistulaG J Reis, A T Hirsch, P C Come
European Journal of Vascular and Endovascular Surgery : the Official Journal of the European Society for Vascular Surgery|August 27, 2013
Pneumatic compression device treatment of lower extremity lymphedema elicits improved limb volume and patient-reported outcomesS C Muluk, A T Hirsch, E C Taffe
The American Journal of Cardiology|October 2, 1990
Potential role of the tissue renin-angiotensin system in the pathophysiology of congestive heart failureA T Hirsch, Y M Pinto, H Schunkert, et al.
The Journal of Clinical Investigation|August 1, 1989
Vasopressin-mediated forearm vasodilation in normal humans. Evidence for a vascular vasopressin V2 receptorA T Hirsch, V J Dzau, J A Majzoub, et al.
The British Journal of Dermatology|June 3, 2017
A comparison of programmable and nonprogrammable compression devices for treatment of lymphoedema using an administrative health outcomes datasetP Karaca-Mandic, A T Hirsch, S G Rockson, et al.
Circulation|August 1, 1995
Clinical trials for claudication. Assessment of exercise performance, functional status, and clinical end points. Vascular Clinical TrialistsW R Hiatt, A T Hirsch, J G Regensteiner, et al.
The American Journal of Medicine|October 5, 1984
Calcium channel blockers as antihypertensive agentsB M Massie, A T Hirsch, I K Inouye, et al.
The American Journal of Physiology|June 11, 1999
Active renin and angiotensinogen in cardiac interstitial fluid after myocardial infarctionA T Hirsch, J A Opsahl, M M Lunzer, et al.
Vascular Medicine (London, England)|January 1, 1997
The role of tobacco cessation, antiplatelet and lipid-lowering therapies in the treatment of peripheral arterial diseaseA T Hirsch, D Treat-Jacobson, H A Lando, et al.
Pageof 6

Showing results (11-20 of 60) with videos related to

Sort By:
Pageof 6
Circulation|May 1, 1987
Baroreceptor function in congestive heart failure: effect on neurohumoral activation and regional vascular resistanceA T Hirsch, V J Dzau, M A Creager
Catheterization and Cardiovascular Diagnosis|January 1, 1988
Detection and treatment of high-output cardiac failure resulting from a large hemodialysis fistulaG J Reis, A T Hirsch, P C Come
European Journal of Vascular and Endovascular Surgery : the Official Journal of the European Society for Vascular Surgery|August 27, 2013
Pneumatic compression device treatment of lower extremity lymphedema elicits improved limb volume and patient-reported outcomesS C Muluk, A T Hirsch, E C Taffe
The American Journal of Cardiology|October 2, 1990
Potential role of the tissue renin-angiotensin system in the pathophysiology of congestive heart failureA T Hirsch, Y M Pinto, H Schunkert, et al.
The Journal of Clinical Investigation|August 1, 1989
Vasopressin-mediated forearm vasodilation in normal humans. Evidence for a vascular vasopressin V2 receptorA T Hirsch, V J Dzau, J A Majzoub, et al.
The British Journal of Dermatology|June 3, 2017
A comparison of programmable and nonprogrammable compression devices for treatment of lymphoedema using an administrative health outcomes datasetP Karaca-Mandic, A T Hirsch, S G Rockson, et al.
Circulation|August 1, 1995
Clinical trials for claudication. Assessment of exercise performance, functional status, and clinical end points. Vascular Clinical TrialistsW R Hiatt, A T Hirsch, J G Regensteiner, et al.
The American Journal of Medicine|October 5, 1984
Calcium channel blockers as antihypertensive agentsB M Massie, A T Hirsch, I K Inouye, et al.
The American Journal of Physiology|June 11, 1999
Active renin and angiotensinogen in cardiac interstitial fluid after myocardial infarctionA T Hirsch, J A Opsahl, M M Lunzer, et al.
Vascular Medicine (London, England)|January 1, 1997
The role of tobacco cessation, antiplatelet and lipid-lowering therapies in the treatment of peripheral arterial diseaseA T Hirsch, D Treat-Jacobson, H A Lando, et al.
Pageof 6